Mallinckrodt Moves Ahead With Plan to Hand Company to Creditors
- Plan has support of certain creditors, unsecured noteholders
- Opioid litigation claims trust to be funded by proposed plan
This article is for subscribers only.
Opioid maker Mallinckrodt Plc filed a plan of reorganization Tuesday that has the support of opioid litigation claimants, holders of 84% in principal amount of unsecured notes and an undisclosed portion of term loan holders, according to court filings.
The plan provides for the company’s revolving credit facility to be paid in full in cash. First- and second-lien term lenders would either be repaid in cash or with new takeback term loans plus cash for accrued interest and other payments, depending on the allowance of each group’s make-whole claims at the time of confirmation.